Tesamorelin 15mg – GHRH Analog & VAT Research Peptide

← Back to WP3 Peptides & Research Index

Tesamorelin 15mg – GHRH Analog & Visceral Adipose Research

Tesamorelin is a synthetic growth hormone–releasing hormone analog. Clinical formulations are approved for specific HIV-associated lipodystrophy indications; here it is discussed only in the context of mechanism-based, non-clinical research on GH/IGF-1 dynamics and visceral fat metabolism.

Request COA, specifications, or compliance details

For Research Use Only. Not for human or veterinary consumption, diagnostic procedures, or therapeutic use. Content is educational and non-promotional.